Now in its eighth consecutive year, HSCI's Seed Grant Program provides two years of critical early funding ($180,000 per grant) to scientists throughout the HSCI community who are engaged in stem cell research. Highest priority is given to those projects that would be difficult to fund from other sources because they are early stage, high risk, or lack sufficient preliminary data. For the second year in a row, HSCI provided a separate category for translational awards in order to help foster efforts to move scientific discovery toward clinical application.
In 2007, the Millipore Foundation made a generous gift of $500,000 to the HSCI Seed Grant Program to support one recipient per year for the next five years. 2012 Seed Grant recipient Tracy Young-Pearse, PhD, of Brigham and Women's Hospital has been named HSCI's final Millipore Foundation Seed Grant Fellow.
In April, award notifications for 10 Seed Grants were sent to the following investigators, who were selected from a pool of many highlyqualified applicants:
Susan Dymecki, MD, PhD, Harvard Medical School
Stephen Haggarty, PhD, Massachusetts General Hospital
Bernhard Kuhn, MD, Boston Children's Hospital
Rohit Kulkarni, MD, PhD, Joslin Diabetes Center
Cammie Lesser, MD, PhD, Massachusetts General Hospital
Michael Mannstadt, MD, Massachusetts General Hospital
Thomas Serwold, PhD, Joslin Diabetes Center
Matthew Steinhauser, MD, Brigham and Women's Hospital
Clifford Tabin, PhD, Harvard Medical School
Tracy Young-Pearse, PhD, Brigham and Women's Hospital